Home
>
US Stocks
>
Avadel Pharmaceuticals plc - ADR
Avadel Pharmaceuticals plc - ADR
AVDL

Avadel Pharmaceuticals plc - ADR (AVDL)

$6.035.78%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$6.4
Today Low/High$6.01 / $6.52
52 Week Low/High$6.11 / $11.59
Market Cap$373.41M

Company Details

Avadel Pharmaceuticals plc is a biopharmaceutical company primarily focused on the development and FDA approval of FT218, an investigational, once-nightly, extended-release formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in adults with narcolepsy.
OrganisationAvadel Pharmaceuticals plc - ADR
HeadquatersDublin, Dublin, Ireland
Employees2.02K
IndustryHealth Technology
CEOGregory Divis

Discover more

Frequently Asked Questions

What is Avadel Pharmaceuticals plc - ADR (AVDL) share price today?

Can Indians buy Avadel Pharmaceuticals plc - ADR (AVDL) shares?

How can I buy Avadel Pharmaceuticals plc - ADR (AVDL) shares from India?

Can Fractional shares of Avadel Pharmaceuticals plc - ADR (AVDL) be purchased?

What are the documents required to start investing in Avadel Pharmaceuticals plc - ADR (AVDL) stocks?